{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:59:20Z","timestamp":1792659560159,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772325"],"award-info":[{"award-number":["81772325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072413"],"award-info":[{"award-number":["82072413"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Excessive osteoclast activation is an important cause of imbalanced bone remodeling that leads to pathological bone destruction. This is a clear feature of many osteolytic diseases such as rheumatoid arthritis, osteoporosis, and osteolysis around prostheses. Because many natural compounds have therapeutic potential for treating these diseases by suppressing osteoclast formation and function, we hypothesized that \u03b1-mangostin, a natural compound isolated from mangosteen, might be a promising treatment as it exhibits anti\u2010inflammatory, anticancer, and cardioprotective effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated the therapeutic effect of \u03b1-mangostin on the processes of osteoclast formation and bone resorption. The receptor activator of nuclear factor-\u03baB (NF-\u03baB) ligand (RANKL) induces osteoclast formation in vitro, and potential pathways of \u03b1-mangostin to inhibit osteoclast differentiation and function were explored. A mouse model of lipopolysaccharide\u2010induced calvarial osteolysis was established. Subsequently, micro-computed tomography and histological assays were used to evaluate the effect of \u03b1-mangostin in preventing inflammatory osteolysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that \u03b1-mangostin could inhibit RANKL-induced osteoclastogenesis and reduced osteoclast\u2010related gene expression in vitro. F-actin ring immunofluorescence and resorption pit assays indicated that \u03b1-mangostin also inhibited osteoclast functions. It achieved these effects by disrupting the activation of NF-\u03baB\/mitogen-activated protein kinase signaling pathways. Our in vivo data revealed that \u03b1-mangostin could protect mouse calvarial bone from osteolysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings demonstrate that \u03b1-mangostin can inhibit osteoclastogenesis both in vitro and in vivo and may be a potential option for treating osteoclast-related diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-022-00589-5","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T08:02:43Z","timestamp":1646467363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["\u03b1-Mangostin inhibits LPS-induced bone resorption by restricting osteoclastogenesis via NF-\u03baB and MAPK signaling"],"prefix":"10.1186","volume":"17","author":[{"given":"Wenkan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-1384","authenticated-orcid":false,"given":"Yiying","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"589_CR1","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2174\/1574888X10666151019115724","volume":"11","author":"E Kylmaoja","year":"2016","unstructured":"Kylmaoja E, Nakamura M, Tuukkanen J. Osteoclasts and remodeling based bone formation. Curr Stem Cell Res Ther. 2016;11:626\u201333.","journal-title":"Curr Stem Cell Res Ther"},{"key":"589_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337\u201342.","journal-title":"Nature"},{"key":"589_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbrc.2016.05.019","volume":"476","author":"NS Soysa","year":"2016","unstructured":"Soysa NS, Alles N. Osteoclast function and bone-resorbing activity: an overview. Biochem Biophys Res Commun. 2016;476:115\u201320.","journal-title":"Biochem Biophys Res Commun"},{"key":"589_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bone.2019.06.023","volume":"127","author":"B Raynaud-Messina","year":"2019","unstructured":"Raynaud-Messina B, Verollet C, Maridonneau-Parini I. The osteoclast, a target cell for microorganisms. Bone. 2019;127:315\u201323.","journal-title":"Bone"},{"key":"589_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00418-018-1636-2","volume":"149","author":"T Ono","year":"2018","unstructured":"Ono T, Nakashima T. Recent advances in osteoclast biology. Histochem Cell Biol. 2018;149:325\u201341.","journal-title":"Histochem Cell Biol"},{"key":"589_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000371845","volume":"61","author":"V Nagy","year":"2015","unstructured":"Nagy V, Penninger JM. The RANKL-RANK story. Gerontology. 2015;61:534\u201342.","journal-title":"Gerontology"},{"issue":"Suppl 1","key":"589_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2165","volume":"9","author":"BF Boyce","year":"2007","unstructured":"Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl 1):S1.","journal-title":"Arthritis Res Ther"},{"key":"589_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.job.2019.01.001","volume":"61","author":"W Feng","year":"2019","unstructured":"Feng W, Guo J, Li M. RANKL-independent modulation of osteoclastogenesis. J Oral Biosci. 2019;61:16\u201321.","journal-title":"J Oral Biosci"},{"key":"589_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L. Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473:139\u201346.","journal-title":"Arch Biochem Biophys"},{"key":"589_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","volume":"5","author":"MC Walsh","year":"2014","unstructured":"Walsh MC, Choi Y. Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond. Front Immunol. 2014;5:511.","journal-title":"Front Immunol"},{"key":"589_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/13543776.2018.1455829","volume":"28","author":"G Chen","year":"2018","unstructured":"Chen G, Li Y, Wang W, Deng L. Bioactivity and pharmacological properties of alpha-mangostin from the mangosteen fruit: a review. Expert Opin Ther Pat. 2018;28:415\u201327.","journal-title":"Expert Opin Ther Pat"},{"key":"589_CR12","doi-asserted-by":"publisher","first-page":"172678","DOI":"10.1016\/j.ejphar.2019.172678","volume":"863","author":"J Markowicz","year":"2019","unstructured":"Markowicz J, Uram L, Sobich J, Mangiardi L, Maj P, Rode W. Antitumor and anti-nematode activities of alpha-mangostin. Eur J Pharmacol. 2019;863:172678.","journal-title":"Eur J Pharmacol"},{"key":"589_CR13","first-page":"188","volume":"83","author":"KJ Zhang","year":"2017","unstructured":"Zhang KJ, Gu QL, Yang K, Ming XJ, Wang JX. Anticarcinogenic effects of \u03b1-mangostin: a review. Planta Med. 2017;83:188\u2013202.","journal-title":"Planta Med"},{"key":"589_CR14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.biopha.2017.05.129","volume":"92","author":"F Wang","year":"2017","unstructured":"Wang F, Ma H, Liu Z, Huang W, Xu X, Zhang X. alpha-Mangostin inhibits DMBA\/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K\/Akt\/mTOR signaling pathway in mice. Biomed Pharmacother. 2017;92:672\u201380.","journal-title":"Biomed Pharmacother"},{"key":"589_CR15","first-page":"81","volume":"15","author":"MH Wang","year":"2017","unstructured":"Wang MH, Zhang KJ, Gu QL, Bi XL, Wang JX. Pharmacology of mangostins and their derivatives: a comprehensive review. Chin J Nat Med. 2017;15:81\u201393.","journal-title":"Chin J Nat Med"},{"key":"589_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00011-019-01232-0","volume":"68","author":"Y Ge","year":"2019","unstructured":"Ge Y, Xu X, Liang Q, Xu Y, Huang M. Alpha-mangostin suppresses NLRP3 inflammasome activation via promoting autophagy in LPS-stimulated murine macrophages and protects against CLP-induced sepsis in mice. Inflamm Res. 2019;68:471\u20139.","journal-title":"Inflamm Res"},{"key":"589_CR17","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3389\/fimmu.2018.02160","volume":"9","author":"SC Gupta","year":"2018","unstructured":"Gupta SC, Kunnumakkara AB, Aggarwal S, Aggarwal BB. Inflammation, a double-edge sword for cancer and other age-related diseases. Front Immunol. 2018;9:2160.","journal-title":"Front Immunol"},{"key":"589_CR18","doi-asserted-by":"publisher","first-page":"740238","DOI":"10.1155\/2015\/740238","volume":"2015","author":"M Taher","year":"2015","unstructured":"Taher M, Mohamed Amiroudine MZ, Tengku Zakaria TM, Susanti D. \u03b1-Mangostin improves glucose uptake and inhibits adipocytes differentiation in 3T3-L1 cells via PPAR\u03b3, GLUT4, and leptin expressions. Evid Based Complementary Altern Med. 2015;2015:740238.","journal-title":"Evid Based Complementary Altern Med"},{"key":"589_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11418-012-0673-8","volume":"67","author":"N Kosem","year":"2013","unstructured":"Kosem N, Ichikawa K, Utsumi H, Moongkarndi P. In vivo toxicity and antitumor activity of mangosteen extract. J Nat Med. 2013;67:255\u201363.","journal-title":"J Nat Med"},{"key":"589_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.intimp.2017.08.021","volume":"52","author":"T Pan","year":"2017","unstructured":"Pan T, Chen R, Wu D, et al. Alpha-mangostin suppresses interleukin-1\u03b2-induced apoptosis in rat chondrocytes by inhibiting the NF-\u03baB signaling pathway and delays the progression of osteoarthritis in a rat model. Int Immunopharmacol. 2017;52:156\u201362.","journal-title":"Int Immunopharmacol"},{"key":"589_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4103\/pm.pm_203_17","volume":"14","author":"Y-H Li","year":"2018","unstructured":"Li Y-H, Hong R-H, Liang Y-M, Pan H-S, Cheng Z-H. Alpha-mangostin suppresses receptor activator nuclear factor-\u03baB ligand-induced osteoclast formation and bone resorption in RAW2647 cells by inhibiting the extracellular signal-regulated kinase and c-Jun N-terminal kinase signaling. Phcog Mag. 2018;14:390.","journal-title":"Phcog Mag"},{"key":"589_CR22","doi-asserted-by":"publisher","first-page":"21913","DOI":"10.3390\/ijms151221913","volume":"15","author":"W Wang","year":"2014","unstructured":"Wang W, Wu C, Tian B, et al. The inhibition of RANKL-induced osteoclastogenesis through the suppression of p38 signaling pathway by naringenin and attenuation of titanium-particle-induced osteolysis. Int J Mol Sci. 2014;15:21913\u201334.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"589_CR23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00223-007-9077-2","volume":"81","author":"C Wedemeyer","year":"2007","unstructured":"Wedemeyer C, Xu J, Neuerburg C, Landgraeber S, Malyar NM, von Knoch F, Gosheger G, von Knoch M, L\u00f6er F, Saxler G. Particle-induced osteolysis in three-dimensional micro-computed tomography. Calcif Tissue Int. 2007;81(5):394\u2013402. https:\/\/doi.org\/10.1007\/s00223-007-9077-2.","journal-title":"Calcif Tissue Int"},{"key":"589_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0004563218759371","volume":"55","author":"JS Kenkre","year":"2018","unstructured":"Kenkre JS, Bassett J. The bone remodelling cycle. Ann Clin Biochem. 2018;55:308\u201327.","journal-title":"Ann Clin Biochem"},{"key":"589_CR25","doi-asserted-by":"publisher","first-page":"14986","DOI":"10.1002\/jcb.28760","volume":"120","author":"X Sheng","year":"2019","unstructured":"Sheng X, Li J, Zhang C, et al. Alpha-mangostin promotes apoptosis of human rheumatoid arthritis fibroblast-like synoviocytes by reactive oxygen species-dependent activation of ERK1\/2 mitogen-activated protein kinase. J Cell Biochem. 2019;120:14986\u201394.","journal-title":"J Cell Biochem"},{"key":"589_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jphs.2015.11.005","volume":"129","author":"P Pan-In","year":"2015","unstructured":"Pan-In P, Wongsomboon A, Kokpol C, Chaichanawongsaroj N, Wanichwecharungruang S. Depositing \u03b1-mangostin nanoparticles to sebaceous gland area for acne treatment. J Pharmacol Sci. 2015;129:226\u201332.","journal-title":"J Pharmacol Sci"},{"key":"589_CR27","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1002\/jcp.25348","volume":"231","author":"S Franceschelli","year":"2016","unstructured":"Franceschelli S, Pesce M, Ferrone A, et al. A novel biological role of \u03b1-mangostin in modulating inflammatory response through the activation of SIRT-1 signaling pathway. J Cell Physiol. 2016;231:2439\u201351.","journal-title":"J Cell Physiol"},{"key":"589_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10753-018-0876-6","volume":"42","author":"W Zou","year":"2019","unstructured":"Zou W, Yin P, Shi Y, et al. A novel biological role of alpha-mangostin via TAK1-NF-kappaB pathway against inflammatory. Inflammation. 2019;42:103\u201312.","journal-title":"Inflammation"},{"key":"589_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1142\/S0192415X19500228","volume":"47","author":"SY Han","year":"2019","unstructured":"Han SY, Kim YK. Berberine suppresses RANKL-induced osteoclast differentiation by inhibiting c-Fos and NFATc1 expression. Am J Chin Med. 2019;47:439\u201355.","journal-title":"Am J Chin Med"},{"key":"589_CR30","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"589_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.","journal-title":"Mol Cancer"},{"key":"589_CR32","doi-asserted-by":"publisher","first-page":"11082","DOI":"10.1096\/fj.201802597RR","volume":"33","author":"D Ke","year":"2019","unstructured":"Ke D, Ji L, Wang Y, et al. JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl-2-Beclin1-autophagy pathway. FASEB J. 2019;33:11082\u201395.","journal-title":"FASEB J"},{"key":"589_CR33","first-page":"1015","volume":"17","author":"Z Fehervari","year":"2016","unstructured":"Fehervari Z. Meta-inflammation and IRF3. Nat Immunol. 2016;17:1015.","journal-title":"Nat Immunol"},{"key":"589_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejphar.2015.03.028","volume":"759","author":"T Komori","year":"2015","unstructured":"Komori T. Animal models for osteoporosis. Eur J Pharmacol. 2015;759:287\u201394.","journal-title":"Eur J Pharmacol"},{"key":"589_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/14786419.2016.1190721","volume":"31","author":"CM Willson","year":"2017","unstructured":"Willson CM, Grundmann O. In vitro assays in natural products research - a matter of concentration and relevance to in vivo administration using resveratrol, \u03b1-mangostin\/\u03b3-mangostin and xanthohumol as examples. Nat Prod Res. 2017;31:492\u2013506.","journal-title":"Nat Prod Res"},{"key":"589_CR36","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.2147\/DDDT.S249865","volume":"14","author":"Q Yin","year":"2020","unstructured":"Yin Q, Wu YJ, Pan S, et al. Activation of cholinergic anti-inflammatory pathway in peripheral immune cells involved in therapeutic actions of \u03b1-mangostin on collagen-induced arthritis in rats. Drug Des Dev Ther. 2020;14:1983\u201393.","journal-title":"Drug Des Dev Ther"},{"key":"589_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.intimp.2017.08.010","volume":"52","author":"T Pan","year":"2017","unstructured":"Pan T, Wu D, Cai N, et al. Alpha-mangostin protects rat articular chondrocytes against IL-1\u03b2-induced inflammation and slows the progression of osteoarthritis in a rat model. Int Immunopharmacol. 2017;52:34\u201343.","journal-title":"Int Immunopharmacol"},{"key":"589_CR38","doi-asserted-by":"publisher","first-page":"107682","DOI":"10.1016\/j.pharmthera.2020.107682","volume":"218","author":"M Honma","year":"2021","unstructured":"Honma M, Ikebuchi Y, Suzuki H. RANKL as a key figure in bridging between the bone and immune system: its physiological functions and potential as a pharmacological target. Pharmacol Ther. 2021;218:107682.","journal-title":"Pharmacol Ther"},{"key":"589_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12:17\u201325.","journal-title":"Trends Mol Med"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-022-00589-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-022-00589-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-022-00589-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T08:26:29Z","timestamp":1646468789000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-022-00589-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s13020-022-00589-5","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were carried out in accordance with the guidelines of the Ethics Committee of Zhejiang University and approved by the Research Ethics Committee of the Second Afliated Hospital of Zhejiang University School of Medicine, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}